Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.80B$2.80Bderived+9.3% vs Q4 2024 Net Income-$112.00M-$112.00MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$474,000,000−15.1% Operating Cash Flowderived$495,000,000−17.6% Free Cash Flowderived$403,000,000−18.6% Margins · derivedOperating margin17.0%−4.9 pt vs Q4 2024
Net margin-4.0%−7.6 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 19, 2026 · 50 d after period end